Home › Funds › Milliman Healthcare Inflation Guard ETF
Fund family: Milliman Funds Trust · Filed by Milliman Funds Trust (CIK 2096904) · SEC series S000101078
Ticker: MHIG (C000271016)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 33 with, 4 against, 0 abstentions (not counted as with management); 1 items carried no recommendation. Shareholder proposals: 0 FOR, 0 AGAINST, 0 abstained, by the filing’s own vote-source field.
No item-level comparison with other Milliman Funds Trust funds is possible: fewer than three other funds of the family voted in 2025-2026.
The same votes as “with management” above, by the sector of the company voted on. 100.0% of this fund’s 37 such votes could be given a sector.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Health Care | 37 | 4 | 10.8% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 23 | 2 |
| Say-on-Pay | 6 | 0 |
| Audit-related | 5 | 0 |
| Compensation | 4 | 2 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Revolution Medicines, Inc. | June 18, 2026 | $834 | 4 | 1 |
| BridgeBio Pharma, Inc. | June 22, 2026 | $619 | 7 | 2 |
| United Therapeutics Corporation | June 26, 2026 | $588 | 15 | 1 |
| Madrigal Pharmaceuticals, Inc. | June 17, 2026 | $424 | 7 | 0 |
| Penumbra, Inc. | June 18, 2026 | $321 | 5 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| June 18, 2026 | Revolution Medicines, Inc. | Elect Director Alexis Borisy | Withhold | For |
| June 22, 2026 | BridgeBio Pharma, Inc. | Elect Director Hannah A. Valantine | Withhold | For |
| June 22, 2026 | BridgeBio Pharma, Inc. | Amend Omnibus Stock Plan | Against | For |
| June 26, 2026 | United Therapeutics Corporation | Approve Omnibus Stock Plan | Against | For |
38 ballot items at 5 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Milliman Healthcare Inflation Guard ETF (MHIG) voted at 5 shareholder meetings of 5 companies, on 38 ballot items in all. Where management made a recommendation, the fund followed it on 89.2% of the items and voted against it 4 times. Its most frequent area of disagreement was director elections (2 of its votes against management).
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.